Stephen D. Skaper
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy.
Journal: Progress in brain research
Published: October 25, 2021
Corrigendum: An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.
Journal: Frontiers in cellular neuroscience
Published: December 12, 2019
Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).
Journal: Journal of orthopaedic translation
Published: September 18, 2019
Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Journal: Progress in brain research
Published: April 10, 2019
Conference Report: 184th American Association for the Advancement of Science Annual Meeting, Austin TX, USA Feb. 15-19, 2018.
Journal: CNS & neurological disorders drug targets
Published: July 12, 2018
Neuroepigenetics and Alzheimer's Disease: An Update.
Journal: Journal of Alzheimer's disease : JAD
Published: July 12, 2018
Commentary: Stephen William Hawking (8 January 1942 - 14 March 2018).
Journal: CNS & neurological disorders drug targets
Published: April 14, 2018
Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).
Journal: Cell transplantation
Published: April 12, 2018
Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017.
Journal: CNS & neurological disorders drug targets
Published: March 28, 2018
Serum amyloid A primes microglia for ATP-dependent interleukin-1β release.
Journal: Journal of neuroinflammation
Published: March 20, 2018
Conference Report: 9th Clinical Trials on Alzheimer's Disease (CTAD).
Journal: CNS & neurological disorders drug targets
Published: February 24, 2018
Last Updated: 09/26/2026